SCHEMBL29296027

SCHEMBL29296027

Cn1cc(C(F)(F)F)nc1-c1ccc(CNc2nc(Cl)ncc2Br)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP1 O94782 12/20 0.39
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ HDAC5 Q9UQL6 1/20 0.37
▸ PDE2A O00408 1/20 0.37
▸ STK17B O94768 1/20 0.37
▸ CSF1R P07333 1/20 0.37
▸ IKBKE Q14164 1/20 0.37
▸ AAK1 Q2M2I8 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.37
▸ ULK3 Q6PHR2 1/20 0.37
▸ NUAK2 Q9H093 1/20 0.37
▸ MKNK2 Q9HBH9 1/20 0.37
▸ PI4KB Q9UBF8 1/20 0.37
▸ TBK1 Q9UHD2 1/20 0.37
▸ CYP2C9 P11712 2/20 0.34
▸ FLT1 P17948 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30032845 1.00 USP1 (0.39) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL29878992 0.89 USP1 (0.39) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL27031623 0.89 USP1 (0.39) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL25978768 0.89 USP1 (0.39) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL27031709 0.88 USP1 (0.39) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL29878759 0.88 USP1 (0.39) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL25430986 0.87 USP1 (0.38) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL25978633 0.87 USP1 (0.43) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL30032988 0.86 USP1 (0.39) USP1HDAC1HDAC8HDAC6HDAC5
SCHEMBL31578460 0.86 USP1 (0.38) USP1HDAC1HDAC8HDAC6HDAC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226107-A1 UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO., LTD. (CN) 2024-07-11 — — US disclosed
US-20240226107-A1 UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO., LTD. (CN) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226107-A1 UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR USP1, USP2, USP3 USP1 1/4885HDAC1 160/4885HDAC8 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback